Calidi Biotherapeutics Inc. (CLDI)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $2.29M
Last updated: Nov 17, 2026 at 11:03 AM ET
Calidi Biotherapeutics Inc. (CLDI) Competitors
The companies most similar to Calidi Biotherapeutics are PharmaCyte Biotech (PMCB), Ernexa Therapeutics (ERNA) and Bioatla (BCAB). By market cap, Calidi Biotherapeutics ranks 9th of the 13 companies on this page; Liminatus Pharma, Inc. Class A Common Stock (LIMN) is the largest at $4.02M.
Peer Comparison
CLDI's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Calidi Biotherapeutics (CLDI) | $2.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| Bioatla Inc (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| Revelation Biosciences Inc (REVB) | $2.43M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| HCW Biologics Inc (HCWB) | $1.73M | N/A | 0.2x | -83.1% | -51.6% | 1970.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| Purple Biotech (PPBT) | $2.65M | N/A | N/A | 0.0% | -156.2% | 0.0% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $4.02M | N/A | N/A | 0.0% | -247.2% | 0.0% | 0.00% |
| Kairos Pharma, Ltd. (KAPA) | $1.54M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Enlivex Therapeutics Ltd (ENLV) | $1.82M | N/A | N/A | 0.0% | -0.3% | 0.0% | 0.00% |
| GRI Bio Inc. (GRI) | $3.72M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Scinai Immunotherapeutics Ltd (SCNI) | $1.05M | N/A | N/A | -80.1% | N/A | 572.0% | 0.00% |
| Peer median | $2.75M | N/A | 0.9x | 0.0% | -103.9% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Calidi Biotherapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Ernexa Therapeutics Inc. (ERNA) | Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. | ERNA competitors |
| Bioatla Inc (BCAB) | BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. | BCAB competitors |
| Revelation Biosciences Inc (REVB) | Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics... | REVB competitors |
| HCW Biologics Inc (HCWB) | HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues... | HCWB competitors |
| Curis Inc (CRIS) | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
| Purple Biotech (PPBT) | Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United... | PPBT competitors |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California. | LIMN competitors |
| Kairos Pharma, Ltd. (KAPA) | Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. | KAPA competitors |
| Enlivex Therapeutics Ltd (ENLV) | Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel. | ENLV competitors |
| GRI Bio Inc. (GRI) | GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology. | GRI competitors |
| Scinai Immunotherapeutics Ltd (SCNI) | Scinai Immunotherapeutics Ltd is an innovative biotechnology company focused on developing cutting-edge immunotherapy solutions for cancer and autoimmune... | SCNI competitors |
Frequently Asked Questions About CLDI
Who are Calidi Biotherapeutics' main competitors?
The companies most similar to Calidi Biotherapeutics include PharmaCyte Biotech (PMCB), Ernexa Therapeutics (ERNA), Bioatla (BCAB), Revelation Biosciences (REVB) and HCW Biologics (HCWB), listed from the closest match.
Who is Calidi Biotherapeutics' biggest competitor?
Liminatus Pharma, Inc. Class A Common Stock (LIMN) is the largest of the similar companies at $4.02M; PharmaCyte Biotech (PMCB) is the closest match by business profile, size, sector and industry.
How does CLDI stock compare with its competitors?
CLDI's net margin is 0.0% against a peer median of 0.0%.
Which of Calidi Biotherapeutics' competitors pays a higher dividend?
Calidi Biotherapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Calidi Biotherapeutics bigger than its competitors?
No. Calidi Biotherapeutics is 9th by market cap among the 13 companies on this page; the largest is Liminatus Pharma, Inc. Class A Common Stock (LIMN) at $4.02M.
CLDI pages: Overview, Earnings, Financials, Competitors